Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $34.5M
- Net income
- -$107.7M
- Net margin
- -312.6%
Little or no net debt.
- Total debt
- $32.6M
- Cash
- $35.8M
- Debt / equity
- 0.21
Comfortably covers what is due within a year.
- Current assets
- $125.2M
- Current liabilities
- $16.7M
- Current ratio
- 7.51
Consumes cash and must keep raising it.
- Operating cash flow
- -$120.6M
- Free cash flow
- -$121.4M
- FCF margin
- -352.4%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 60.5M
- Share growth (1y)
- 3.2%
- Cash runway
- 4 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VYGR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 3.17 M | 2.59 M | 15.34 M | 13.37 M | 5.20 M | 6.47 M |
| Revenue Growth (YoY) | -39.13 % | -59.94 % | 144.28 % | -45.73 % | -82.42 % | -66.83 % |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 3.17 M | 2.59 M | 15.34 M | 13.37 M | 5.20 M | 6.47 M |
| SG&A Expense | 7.52 M | 8.26 M | 9.32 M | 8.09 M | 10.49 M | 9.64 M |
| R&D Expense | 22.04 M | 24.60 M | 35.95 M | 35.87 M | 31.33 M | 31.53 M |
| Operating Expenses | 29.56 M | 32.86 M | 45.27 M | 43.96 M | 41.83 M | 41.17 M |
| Operating Income | -26.39 M | -30.27 M | -29.93 M | -30.59 M | -36.63 M | -34.69 M |
| Pretax Income | -24.45 M | -27.92 M | -27.42 M | -27.81 M | -33.37 M | -30.98 M |
| Tax Provision | 20.00 K | 14.00 K | 9.00 K | 83.00 K | 15.00 K | 37.00 K |
| Net Income | -24.47 M | -27.94 M | -27.43 M | -27.89 M | -33.38 M | -31.02 M |
| EPS (Basic) | -0.40 | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 |
| EPS (Diluted) | -0.40 | -0.47 | -0.47 | -0.47 | -0.57 | -0.53 |
| Shares Outstanding | 60.55 M | 59.50 M | 58.69 M | 58.80 M | 58.67 M | 58.35 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.